Envestnet Asset Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-268
Closed -$340K 3675
2021
Q2
$340K Buy
+268
New +$302K ﹤0.01% 3213
2021
Q1
Sell
-174
Closed -$248K 3512
2020
Q4
$248K Buy
+174
New +$186K ﹤0.01% 3018

Other funds holding CDLX

Envestnet Asset Management's CDLX Position: Q3 2021 in Review

Envestnet Asset Management sold out of Cardlytics (CDLX) in Q3 2021, closing a stake of 268 shares — an estimated $340K sold.

Envestnet Asset Management first reported a position in CDLX in Q4 2020 and held it in 2 quarters. The position peaked at $340K in Q2 2021. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2021.

  • Envestnet Asset Management reported no remaining Cardlytics position as of Q3 2021 after selling out during the quarter.
  • Envestnet Asset Management sold 268 Cardlytics shares in Q3 2021, an estimated $340K.
  • Envestnet Asset Management first reported a position in Cardlytics in Q4 2020 and held it in 2 quarters.
  • Envestnet Asset Management's Cardlytics position peaked at $340K in Q2 2021.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2021.

Based on Envestnet Asset Management's 13F filing for Q3 2021, filed 7 Oct 2021.